Uncategorized
« Previous Entries Next Entries »The FDA and Overseas Drug Approvals
Monday, March 31st, 2008Submitted by BioHealth Investor Blog
by Mark Senak
Eye On FDA
Where is the Most Promising Pipeline?
For a while now, I’ve been thinking about the growing number of drugs that are being approved overseas and going on the market overseas, but are not getting approved or are getting approvable letters in the U.S. It is a list that […]
Fund Mangers bullish on pharma stocks in the long run
Friday, March 28th, 2008Submitted by THE HEALTH ECONOMICS BLOG
FT.com site : View of the day: Pharmaceuticals.
March 27, 2008Financial Times (FT.Com)
The market’s attitude towards the pharmaceutical industry has changed dramatically over the last decade. The rise of generics, perceived pipeline issues and pricing have all led to a major de-rating of these stocks. This presents a huge opportunity,” says […]
NICE recommends Sanofi Aventis’ Obesity drug
Friday, March 28th, 2008Submitted by THE HEALTH ECONOMICS BLOG
by Michael McKenna
“The UK’s National Institute for Health and Clinical Excellence on Wednesday issued final appraisal determination recommending that sanofi-aventis’ obesity drug, Acomplia (rimonabant), be made available on the NHS for certain patients. Sanofi-aventis noted that a final decision from NICE is expected in “due course.”
The agency recommended that the […]
Friday’s Top Medical & Biotech Stocks
Friday, March 28th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
PROTEO INC [PTEO.OB] +93.07%
BIOSANTE PHARMA INC [BPAX] +19.39%
TRANSDEL PHARMACTL [TDLP.OB] +19.20%
HESKA CORPORATION [HSKA] +18.52%
HEMOBIOTECH INC [HMBT.OB] +18.18%
Diagnostic Substances
REMOTEMDX INC [RMDX.OB] +13.42%
RESPONSE GENETICS, I [RGDX] +8.11%
INFINITY PHARMACEUTI [INFI] +6.82%
SYNTA PHARMACEUTICAL […]
Drugs: Penny Wise, But a Pound Foolish
Friday, March 28th, 2008Submitted by BioHealth Investor Blog
by Michael Shulman
BiotechBlitz
I typically write about stocks of interest to investors, but today I am just hacked off. Bear with me and pardon the pun.
Not all drugs and biotech companies are created equal — and the belief that a drug may cost too much because of its price, is representative of […]
Thursday’s Top Medical & Biotech Stocks
Friday, March 28th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
IMMUNOSYN CORPORATIN [IMYN.OB] +19.90%
BIOSANTE PHARMA INC [BPAX] +19.88%
TITAN PHARMA INC [TTP] +14.17%
REXAHN PHARMACEUTICL [RXHN.OB] +13.64%
ANESIVA INC [ANSV] +10.00%
Diagnostic Substances
IMMUCELL CP [ICCC] +25.02%
TORREYPINES THERAPEU [TPTX] +18.32%
REMOTEMDX INC [RMDX.OB] +10.37%
AVANT IMMUNOTHERAPEU […]
Pharma 2020
Tuesday, March 25th, 2008Submitted by THE HEALTH ECONOMICS BLOG
PriceWaterhouseCoopers (PwC) published a report: Pharma 2020: The vision: Which path will you take?
PWC indicates that the current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. In order to make the most […]
Painting the Colon: Early Stage Cancer Detection without Biopsy
Friday, March 21st, 2008Submitted by BioHealth Investor Blog
by Doug Cress
Med Tech Sentinel
Most cases of colon cancer begin as small noncancerous polyps. Over time these polyps may become colon cancers. Regular screening helps identify polyps before they become cancerous, allowing for prophylactic treatment.
According to the American Cancer Society, 112,000 people are diagnosed with colon cancer annually.
The most common and […]
Thursday’s Top Medical & Biotech Stocks
Friday, March 21st, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
IOMAI CORPORATION [IOMI] +27.62%
TRUBION PHARMACEUTIC [TRBN] +22.18%
SEQUENOM INC [SQNM] +17.59%
BIOSPECIFICS TECH CP [BSTC.OB] +14.85%
3SBIO INC [SSRX] +13.82%
Diagnostic Substances
ISTA PHARMACTLS [ISTA] +12.56%
TRINITY BIO ADR [TRIB] +10.84%
IMMUNOMEDICS INC [IMMU] +9.72%
INFINITY PHARMACEUTI […]
Amgen: Whither Thou Goest?
Thursday, March 20th, 2008Submitted by BioHealth Investor Blog
by Michael Shulman
BiotechBlitz
I have disliked Amgen (AMGN) for a very long time and have the good fortune of having two publishing platforms to discuss the company: my ChangeWave Biotech Investor service and my short service, ChangeWave Shorts.
I write about it whenever I hear “value” investors who know nothing about biotech or […]
Wednesday Recap: Biotech Restructuring Day!
Thursday, March 20th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub, DMD
BioHealth Investor
Nasdaq Biotechnology Index (^NBI) -2.92%
Amex Pharmaceutical Index (^DRG) -2.69%
iShares Dow Jones Medical Devices (IHI) -1.25%
Kosan Biosciences (KOSN) up 24.34%… investors were cheering the company’s appointment of a new CEO, and its announcement that it will cut 37% of its workforce and refocus its clinical efforts to only […]
Wednesday’s Top Medical & Biotech Stocks
Thursday, March 20th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
KOSAN BIOSCIENCES [KOSN] +24.34%
HALOZYME THERAPEUTIC [HALO] +23.17%
METABASIS THERAPEUTI [MBRX] +17.68%
BARRIER THERAPEUTICS [BTRX] +10.83%
DISCOVERY LABS INC [DSCO] +10.70%
Diagnostic Substances
LEXICON PHARMACEUTCL [LXRX] +10.31%
RESPONSE GENETICS, I [RGDX] +8.00%
ISTA PHARMACTLS [ISTA] +7.57%
HUMAN GENOME […]
Another Silly Bio-Generics Bill
Wednesday, March 19th, 2008Submitted by BioHealth Investor Blog
by David E. Williams
Health Business Blog
Two Congressional Reps have introduced a bill to create a pathway for generic biopharmaceuticals. It seems to me like a big waste of time.
The bill has the following key provisions, according to Kaiser Daily Health Policy Report:
12-14.5 years of market exclusivity for the original product before […]
Tuesday Recap: Medical & Biotech Stocks
Wednesday, March 19th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub, DMD
BioHealth Investor
Nasdaq Biotechnology Index (^NBI) +2.85%
Amex Pharmaceutical Index (^DRG) +2.30%
iShares Dow Jones Medical Devices (IHI) +3.03%
Ista Therapeutics (ISTA) up 39.10%… Well, I guess the company’s presentation at the Cowen & Company 28th Annual Health Care Conference in Irvine, California went well today. The company’s President and CEO was […]
China a Priority for AstraZeneca
Wednesday, March 19th, 2008Submitted by BioHealth Investor Blog
by Richad Daverman, PhD
ChinaBio Today
Expanding the presence of AstraZeneca (NYSE: AZN) in the Asia-Pacific region in general and China specifically is a priority for AstraZeneca, according to John Ramsey, AstraZeneca’s Vice President for Global Development. Ramsey made the remarks in an interview with EView Week.
Ramsey stressed that AstraZeneca is interested in […]
Tuesday’s Top Medical & Biotech Stocks
Wednesday, March 19th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
SUNESIS PHARMACEUTIC [SNSS] +31.58%
DARA BIOSCIENCES [DARA] +24.56%
RXI PHARMACEUTICALS [RXII] +22.16%
TERCICA INC [TRCA] +19.11%
BIONOVO INC [BNVI] +15.25%
Diagnostic Substances
ISTA PHARMACTLS [ISTA] +39.10%
QUIDEL CP [QDEL] +6.62%
MERIDIAN BIOSCIENC [VIVO] +6.34%
ABAXIS INC [ABAX] +5.97%
AMAG […]
Despite Media Carping, Americans Largely Trust Drug Companies
Tuesday, March 18th, 2008Submitted by BioHealth Investor Blog
by Nathan Burchfiel
Business & Media Institute
Media attacks on pharmaceutical companies don’t resonate with the public, which overwhelmingly believes drug makers improve quality of life.
Seven out of ten Americans believe prescription drugs developed over the past 20 years have made life better for their fellow Americans – in spite of journalists’ incessant […]
Monday Recap: Medical & Biotech Stocks
Tuesday, March 18th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub, DMD
BioHealth Investor
QLT Inc. (QLTI) up 41.63%… The FDA has completed its review the company’s labeling supplement (sNDA) for Aczone(TM) and has removed certain requirements imposed earlier. Aczone is the only acne treatment to use the potential of dapsone in a topical formulation.
Nuvelo (NUVO) down 26.47% aftermarket 4:40pm… the […]
Monday’s Top Medical & Biotech Stocks
Tuesday, March 18th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
QLT INC [QLTI] +41.63%
TRUBION PHARMACEUTIC [TRBN] +18.55%
GENVEC INC [GNVC] +10.17%
CADENCE PHARM. INC. [CADX] +9.57%
CV THERAPEUTICS I [CVTX] +7.78%
Diagnostic Substances
SCOLR PHARMA INC [DDD] +5.69%
IMMUCELL CP [ICCC] +4.56%
INTERLEUKIN GENETICS [ILI] +2.76%
ASPENBIO […]
Health Economics & Outcomes Research Opening at Epi-Q
Tuesday, March 18th, 2008Submitted by THE HEALTH ECONOMICS BLOG
I am posting below job opportunity on behalf of Andrew Baker, VP Business Development at Epi-Q. Interested candiates please get in touch with Drew.
HEALTH ECONOMICS AND OUTCOMES RESEARCH SCIENTIST
EPI-Q, Inc., an established consulting firm to the life sciences and healthcare provider and payer industries, seeks an experienced outcomes researcher for […]
German IQWIG publishes presentations from the fall symposium on cost-benefit assessments of pharmaceuticals
Tuesday, March 18th, 2008Submitted by THE HEALTH ECONOMICS BLOG
The German IQWIG has published the presentations from the fall symposium.
To access the files click here. The talks on costing methods and modeling are unfortunately in German only.
Please find a list of the available speeches on the IQWIG website below:
Prof. Dr. med. Peter T. Sawicki, Welcome (German)
PD Dr. med. Peter […]
German IQWIG publishes presentations from the fall symposium on cost-benefit assessments of pharmaceuticals
Tuesday, March 18th, 2008Submitted by THE HEALTH ECONOMICS BLOG
The German IQWIG has published the presentations from the fall symposium.
To access the files click here. The talks on costing methods and modeling are unfortunately in German only.
Please find a list of the available speeches on the IQWIG website below:
Prof. Dr. med. Peter T. Sawicki, Welcome (German)
PD Dr. med. Peter […]
Shire braced
Monday, March 17th, 2008Submitted by PharmaGossip Blog
Shire Pharmaceuticals, Britain’s third-biggest drugs company, is on standby for a bid from Pfizer, the US group that developed Viagra.
Shares in Shire leapt 47p to 990p on Friday, as analysts predicted an offer as high as £13 a share, valuing the company at £8bn.
Source
Rating 3.00 out of 5
[?]
JP Morgan Grabs Bear Stearns for $2; Long Recession Ahead
Monday, March 17th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub, DMD
BioHealth Investor
I know this is supposed to be a blog covering the biotechnology and medical industry, but in an unprecedented move for this blog, a major non-health related event will have to be commented on.
Bear Steans (BSC) was forced to sell itself to JP Morgan (JPM) for a […]
Hacking the Heart
Monday, March 17th, 2008Submitted by BioHealth Investor Blog
by Doug Cress
Med Tech Sentinel
A team of computer security researchers have remotely hacked Medtronic’s (MDT) Maximo – a stopwatch-sized implantable cardiac defibrillator.
Armed with an antenna, radio hardware and a PC, the team was able to shut down and manipulate the device – and even deliver potentially lethal jolts of electricity.
The investigation […]
